BioCentury
ARTICLE | Company News

NGM, Daiichi in beta cell regeneration deal

March 30, 2012 12:48 AM UTC

NGM Biopharmaceuticals Inc. (South San Francisco, Calif.) and Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568) partnered to discover and develop therapeutics that modulate beta cell regeneration to tr...